Wegovy maintenance

What Wegovy maintenance actually means

Maintenance is a phase of treatment, not the end of it. Wegovy's approved schedule climbs 0.25 to 0.5 to 1 to 1.7 mg, reaching 2.4 mg at around week seventeen, and 2.4 mg is the maintenance dose. Not a peak you come down from.

That trips people up because most medication courses have an end. Antibiotics finish. Wegovy is licensed as long-term treatment for a chronic condition, and the trials that established it kept people on it. When weight stabilises at 2.4 mg, the drug has not stopped working — it is doing the second half of its job.

The titration schedule tool maps the whole escalation with dates if you want to see where you are in it.

Do You Lose Weight on the Maintenance Dose of Wegovy?

Yes, patients continue losing weight during the early maintenance phase, but weight loss does not continue indefinitely.

When patients transition from 1.7 mg to the 2.4 mg maintenance dose around month four, appetite suppression and gastric emptying delay reach their full therapeutic strength. In the 68-week STEP 1 and STEP 4 trials, patients continued to lose weight through weeks 20 to 60. However, around week 60 to week 68, the rate of weight loss naturally flattens into a plateau.

This plateau is not drug resistance or medication failure. It is fundamental human physiology: as you lose 15% to 20% of your body weight, your basal metabolic rate (BMR) decreases, your body requires fewer daily maintenance calories, and neuroendocrine signals adjust. At that point, the 2.4 mg maintenance dose transitions from driving active loss to actively defending your new lower set point against metabolic rebound.

Wegovy Maintenance Dose After Reaching Goal Weight

Reaching your target weight on Wegovy presents an immediate clinical decision: what do you do with your weekly 2.4 mg injection now that active fat loss is complete? In clinical practice, prescribers navigate three primary pathways:

1. Continuing 2.4 mg Weekly (The Trial Standard): In STEP 4, continuing 2.4 mg was the only protocol that guaranteed 100% preservation of weight loss and cardiovascular risk reduction over the 68-week study period.
2. Stepping Down to 1.7 mg or 1.0 mg (Clinician-Supervised Taper): Some patients who have reached their target weight find that 2.4 mg continues to suppress appetite excessively or wish to reduce medication costs. Stepping down to 1.7 mg or 1.0 mg allows patients to evaluate whether a lower dose can keep food noise quiet without triggering weight regain.
3. Dose Stretching (Every 10 to 14 Days): While commonly improvised by patients, extending injection intervals causes wide swings in blood concentration due to semaglutide's 7-day half-life. By day 10–12, blood levels drop significantly, causing sudden food noise spikes followed by nausea upon re-injection. Most obesity specialists recommend consistent weekly lower doses rather than irregular stretched intervals.

The evidence for staying on

STEP 4 was designed to answer exactly this question, and its answer is unusually clean. Participants ran in on semaglutide for 20 weeks, then were randomised either to continue at 2.4 mg or to switch to placebo.

Same people, same starting point, one decision, a 14.8-point spread. The longer-horizon version comes from the STEP 1 extension, where people who stopped regained about two-thirds of their lost weight over the following year.

There is a second argument that has nothing to do with weight. SELECT randomised 17,604 adults with cardiovascular disease and obesity to semaglutide 2.4 mg or placebo and found major adverse cardiovascular events in 6.5% versus 8.0% over a mean of 39.8 months. If that benefit is part of why you are on it, it is a benefit that requires being on it.

Plateau versus maintenance

A plateau is weight loss stopping while you are still climbing or still expect to lose. Maintenance is weight holding on purpose. They feel identical and mean different things.

The distinction matters because the responses are opposite. A plateau at week ten on 1 mg usually means the dose has not finished escalating, or that intake has drifted, or that both are true. Stable weight at month nine on 2.4 mg after a substantial loss is closer to the treatment doing what it was prescribed to do.

Three questions separate them: is the dose still climbing, has food noise changed, and has protein or portion size drifted. Weight alone cannot tell you, which is why weight alone is a poor maintenance metric. Waist measurements, strength, blood pressure, glucose control and the volume of food noise all carry information the scale does not.

Can you maintain on a lower dose?

Some people do, and it is a legitimate conversation — but Wegovy's licensed maintenance dose is 2.4 mg, and the maintenance evidence was generated at 2.4 mg.

Reasons people ask are usually cost, side effects, or supply. Each has a different best answer, and only one of them is "take less". Side effects at maintenance are worth reporting rather than solving privately, because they are often manageable without changing dose. Cost has named alternatives that do not involve rationing. Supply gaps are events to plan a restart around.

What is worth agreeing in advance either way is the threshold: how much regain, or how much returning food noise, triggers a review. A number decided in advance beats a judgement call made while it is happening.

What changes when the losing stops

Maintenance has its own failure modes, and they are not the ones from the losing phase.

• Protein slips. Appetite is still suppressed but the urgency is gone, and protein is the first thing to fall. It is also the main defence against losing lean tissue. A target number helps more than intention — the protein calculator gives you one.
• Weighing stops. Understandable, and it removes the signal that would have caught drift at three pounds instead of fifteen.
• Food noise creeps back. Usually gradual, usually before the scale moves. The most useful early indicator there is.
• Resistance training gets dropped. It mattered during loss and it matters more during maintenance, when the goal is keeping what you rebuilt.
• Appointments get further apart. Which is fine, as long as somebody is still watching the numbers.

What to track through a transition

The useful signals move before the scale does, and none of them are things anyone remembers accurately three weeks later. If you are changing anything about your treatment, these four are worth writing down as they happen:

• Food noise. Intrusive food thoughts, grazing urges, whether old portions have started looking normal again. This is usually the first thing to move.
• Hunger pattern. Not just how often, but whether meals still finish the feeling.
• Weight trend, weekly. A seven-day average, not a daily number. Daily weights during a transition mostly measure hydration and generate anxiety.
• Dose history. Exact dates of every change, missed dose, dose stretch, side effect and supply gap. This is the part clinicians most often ask about and patients most often cannot answer.

The point is not to become a data project. It is that "hunger came back around week three and I was up four pounds by week six" is a conversation that produces a plan, while "I think it's been getting worse" is not.

Common questions

What is the maintenance dose of Wegovy?

2.4 mg once weekly, reached at around week seventeen on the standard escalation. It is the dose used in the STEP weight-management trials and in the SELECT cardiovascular outcomes trial.

Do you lose weight on the maintenance dose of Wegovy?

In STEP 4, participants continuing at 2.4 mg lost an additional 7.9% of body weight between weeks 20 and 68 before weight loss plateaued. The maintenance dose initially extends weight loss, but its primary long-term biological function is defending your new lower set point against metabolic rebound.

What is the Wegovy maintenance dose after reaching goal weight?

The FDA-approved maintenance dose remains 2.4 mg once weekly. Some clinicians evaluate stepping down to 1.7 mg or 1.0 mg for patients who maintain weight stability and wish to minimize cost or side effects, but stopping entirely results in rapid regain for two-thirds of patients.

How long do you stay on Wegovy?

It is licensed as long-term treatment for a chronic condition rather than a fixed course. The trial evidence is specifically that continuing maintains the result and stopping largely reverses it. How long applies to you is a clinical decision, but the default in the evidence is ongoing.

Can you maintain weight loss on a lower Wegovy dose?

Some people do, and it is a reasonable question to raise, but 2.4 mg is the licensed maintenance dose and where the maintenance evidence comes from. Lower-dose maintenance is a prescriber decision, not something to trial between appointments.

Is a Wegovy plateau the same as maintenance?

No. A plateau is weight loss stalling while you still expect to lose, often because the dose is still escalating or intake has drifted. Maintenance is weight holding by design at the maintenance dose. The tell is whether food noise, protein and portion size have changed.

What happens if I stop Wegovy after reaching my goal?

In STEP 4, people switched to placebo after a 20-week run-in gained 6.9% over the following 48 weeks while those continuing lost a further 7.9%. In the STEP 1 extension, about two-thirds of lost weight returned within a year of stopping.

Keep reading